Truist Financial
EDVA

Truist Financial’s Endovia Health Sciences, Inc. EDVA Stock Holding History

Truist Financial’s Portfolio EDVA Stock Details EDVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.5K Buy
16,955
+8,750
+107% +$9.06K ﹤0.01% 2913
2026
Q1 		$11.8K Buy
+8,205
New +$19K ﹤0.01% 2785

Other funds holding EDVA

Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
PM
Phraction Management Colchester, Connecticut $596M AUM 36.77% 1-Year Est. Return
STA
Summit Trail Advisors New York $7.95B AUM 26.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
LWM
Lifetime Wealth Management Rockwall, Texas $171M AUM
CFM
Compass Financial Management Tampa, Florida $829M AUM
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
SG
StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return

Truist Financial's EDVA Position: Q2 2026 in Review

Truist Financial increased its Endovia Health Sciences, Inc. (EDVA) stake by 107% in Q2 2026, buying an estimated $9.06K and bringing the position to 16,955 shares worth $10.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2913.

Truist Financial first reported a position in EDVA in Q1 2026 and has held it in 2 quarters since. The position peaked at $11.8K in Q1 2026. 18 funds tracked by Wall St. Rank hold EDVA as of Q2 2026.

  • Truist Financial held 16,955 shares of Endovia Health Sciences, Inc. worth $10.5K as of Q2 2026.
  • Truist Financial bought 8,750 Endovia Health Sciences, Inc. shares in Q2 2026, an estimated $9.06K.
  • Endovia Health Sciences, Inc. made up ﹤0.01% of Truist Financial's portfolio in Q2 2026, its #2913 holding.
  • Truist Financial first reported a position in Endovia Health Sciences, Inc. in Q1 2026 and has held it in 2 quarters since.
  • Truist Financial's Endovia Health Sciences, Inc. position peaked at $11.8K in Q1 2026.
  • 18 funds tracked by Wall St. Rank held Endovia Health Sciences, Inc. as of Q2 2026.

Based on Truist Financial's 13F filing for Q2 2026, filed 28 Jul 2026.